Analyst Ratings for Acumen Pharmaceuticals, Inc. (ABOS)
ABOS Rating Summary
ABOS Price Target Summary
- Highest: $10.00 (Stifel)
- Lowest: $6.00 (Lucid Capital Markets)
- Average: $8.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$8.00 (+254%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$8.00 (+254%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/17/2025 | Lucid Capital Markets | N/A | New Coverage | Buy (N/A) |
6.00 (N/A) |
2.10 (2.26) |
7.62% | Details |
| 6/17/2025 | Citi | Geoff Meacham | New Coverage | Buy (N/A) |
4.00 (N/A) |
1.14 (2.26) |
98.25% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
